COMPUGEN LTD
Datakwaliteit: 100%
CGEN
NASDAQ
Manufacturing
Chemicals
€ 2,89
€ 0,00
(0,00%)
6 months return
—
Momentum
Neutral
5Y revenue growth
86,61%
Groei
Revenue Growth (5Y)
86,61%
Boven sectorgemiddelde (1,92%)
Revenue (1Y)161,14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
65,09%
Boven sectorgemiddelde (-54,47%)
ROIC36,51%
Net Margin48,57%
Op. Margin43,05%
Veiligheid
Debt / Equity
N/A
Current Ratio4,74
Interest Coverage1118,79
Waardering
PE (TTM|NTM)
6,60 | -8,67
Boven sectorgemiddelde (-1,50)
P/B Ratio4,64
EV/EBITDA7,24
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 86,61% annually over 5 years — strong growth
ROE of 65,09% indicates high profitability
Net margin of 48,57% shows strong profitability
Generating 31,33 M in free cash flow
P/E of 6,60 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 74,53%
Price History
Financiële Trends
Koersdoel Analisten
6 analisten
Buy
+101.8%
upside to target
Huidig
€ 2,89
Consensus Target
€ 5,83
€ 4,00
Laag
€ 13,00
Hoog
Vooruitzicht
Forward K/W
-8,67
Forward WPA
-€ 0,33
Omzet Sch.
21,55 M
Winstverassingen
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -€ 0,08
·
Rev Est: 1,26 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -€ 0,08 | -€ 0,08 | -€ 0,07 | € 0,60 | — | — |
| Estimate | -€ 0,05 | -€ 0,09 | -€ 0,09 | € 0,14 | -€ 0,08 | -€ 0,08 |
| Verrassing | -60,00% | +5,88% | +22,22% | +339,01% | — | — |
Growth
Rev 5Y: 86,61% · Earnings 1Y: N/A
Growth
Rev 5Y: 86,61% · Earnings 1Y: N/A| Revenue Growth (1Y) | 161,14% | Revenue Growth (3Y) | 47,47% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 86,61% | Earnings Growth (5Y) | N/A |
Profitability
ROE: 65,09% · Net Margin: 48,57%
Profitability
ROE: 65,09% · Net Margin: 48,57%| Revenue (TTM) | 72,76 M | Net Income (TTM) | 35,34 M |
| ROE | 65,09% | ROA | 32,62% |
| Gross Margin | 87,29% | Operating Margin | 43,05% |
| Net Margin | 48,57% | Free Cash Flow (TTM) | 31,33 M |
| ROIC | 36,51% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 4,74
Safety
D/E: N/A · Current: 4,74| Debt / Equity | N/A | Current Ratio | 4,74 |
| Interest Coverage | 1118,79 | Asset Turnover | 0,67 |
| Working Capital | 77,06 M | Tangible Book Value | 50,26 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: 6,60 · EV/EBITDA: 7,24
Valuation
P/E: 6,60 · EV/EBITDA: 7,24| P/E Ratio | 6,60 | Forward P/E | -8,67 |
| P/B Ratio | 4,64 | P/S Ratio | 3,20 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 7,24 | Fwd EV/EBITDA | N/A |
| Forward P/S | 10,82 | Fwd Earnings Yield | N/A |
| FCF Yield | 13,44% | ||
| Market Cap | 233,15 M | Enterprise Value | 226,68 M |
Per Share
EPS: 0,38 · FCF/Share: 0,33
Per Share
EPS: 0,38 · FCF/Share: 0,33| EPS (Diluted TTM) | 0,38 | Revenue / Share | 0,77 |
| FCF / Share | 0,33 | OCF / Share | 0,33 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 88,64% · CapEx/Rev: 0,42%
Efficiency
FCF Conv: 88,64% · CapEx/Rev: 0,42%| CapEx / Revenue | 0,42% | FCF Conversion | 88,64% |
| SBC-Adj. FCF | 24,74 M | Growth Momentum | 74,53 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 72,76 M | 27,86 M | 33,46 M | 7,50 M | 6,00 M |
| Net Income | 35,34 M | -14,23 M | -18,75 M | -33,69 M | -34,20 M |
| EPS (Diluted) | 0,38 | -0,16 | -0,21 | -0,39 | -0,41 |
| Gross Profit | 63,51 M | 19,93 M | 31,46 M | 6,53 M | 5,32 M |
| Operating Income | 31,33 M | -14,89 M | -12,99 M | -35,37 M | -35,07 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 22,76 M | 24,81 M | 34,47 M | 30,65 M | 28,69 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 28.000,0 | 34.000,0 | 31.000,0 | 27.000,0 | 25.000,0 |
| Income Tax | 54.000,0 | 4,52 M | 8,97 M | 58.000,0 | -722.000,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 156,57 M | 115,00 M | 121,33 M | 94,18 M | 132,16 M |
| Total Liabilities | — | — | — | — | — |
| Shareholders' Equity | 102,73 M | 54,91 M | 65,56 M | 77,68 M | 106,69 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 90,60 M | 18,23 M | 13,89 M | 11,06 M | 7,80 M |
| Current Assets | 148,02 M | 106,00 M | 114,58 M | 86,13 M | 123,22 M |
| Current Liabilities | 22,57 M | 20,16 M | 26,27 M | 11,92 M | 17,10 M |
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 6,6 | -1,5 |
| P/B | 4,6 | 1,6 |
| ROE % | 65,1 | -54,5 |
| Net Margin % | 48,6 | -41,5 |
| Rev Growth 5Y % | 86,6 | 1,9 |
| D/E | — | 0,3 |
Strategiescores
1 strategy matched
Strategiescores
1 strategy matched
Growth
Capital Light Compounder
#2 of 85
Recente Activiteit
Ingestapt
Capital Light Compounder
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"CGEN","listing_kind":"stock","pathname":"/stocks/cgen","exchange":"NASDAQ","country":"US"}}